Narrow Results By
Bill C-2 An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act)
https://policybase.cma.ca/link/policy11297
Bill C-17 An Act to amend the Food and Drugs Act
https://policybase.cma.ca/link/policy11196
Canadian Medical Association submission to the Standing Senate Committee on Banking, Trade and Commerce: Higher rate now: Why excise tax on tobacco is long overdue for an increase
https://policybase.cma.ca/link/policy11129
- Date
- 2014-05-15
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs
CMA's Submission to the Senate Committee on Social Affairs, Science and Technology as part of its study on prescription pharmaceuticals: Federal levers to address unintended consequences of prescription pharmaceuticals and support public health, quality care, and patient safety
https://policybase.cma.ca/link/policy11125
Consultation on the prescription drug list: Naloxone
https://policybase.cma.ca/link/policy11847
Health Canada’s Consultation on “Plain and Standardized Packaging”
https://policybase.cma.ca/link/policy13817
- Date
- 2016-08-12
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs
The Health risks and harms associated with the use of marijuana
https://policybase.cma.ca/link/policy11138
Legalization, regulation and restriction of access to marijuana
https://policybase.cma.ca/link/policy11954
National pharmacare in Canada: Getting there from here
https://policybase.cma.ca/link/policy11959
Proposed amendments to the marihuana for medical purposes regulations
https://policybase.cma.ca/link/policy11293
Regulation of Self-Care Products in Canada
https://policybase.cma.ca/link/policy13802
- Date
- 2016-10-31
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
- Health care and patient safety
Regulatory framework for the mandatory reporting of adverse drug reactions and medical device incidents by provincial and territorial healthcare institutions.
https://policybase.cma.ca/link/policy11814
- Date
- 2016-01-20
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
- Health care and patient safety
Review of Controlled Drugs and Substances Act: Canadian Medical Association submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations
https://policybase.cma.ca/link/policy11114
Statement to the House of Commons Committee on Health addressing the opioid crisis in Canada
https://policybase.cma.ca/link/policy13936
- Date
- 2016-10-18
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
- Population health, health equity, public health
- Health care and patient safety
- Policy Type
- Parliamentary submission
- Date
- 2016-10-18
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
- Population health, health equity, public health
- Health care and patient safety
Documents
Tamper Resistance under the Controlled Drugs and Substances Act
https://policybase.cma.ca/link/policy11295
- Date
- 2014-08-26
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs